Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred R Hirsch

Showing results (161-170 of 407) with videos related to

Pageof 41
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2018
Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naïve LesionsKenichi Suda, Jihye Kim, Isao Murakami, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 23, 2013
Volatile fingerprints of cancer specific genetic mutationsNir Peled, Orna Barash, Ulrike Tisch, et al.
Translational Lung Cancer Research|February 4, 2020
T cell immunoglobulin and mucin-domain containing-3 in non-small cell lung cancerKeyi Jia, Yayi He, Rafal Dziadziuszko, et al.
Biomed Research International|November 10, 2017
Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell LinesKenichi Suda, Leslie Rozeboom, Koh Furugaki, et al.
Oncology Letters|June 13, 2019
Frequency and significance of epidermal growth factor receptor mutations detected by PCR methods in patients with non-small cell lung cancerEiji Nakajima, Michio Sugita, Kinya Furukawa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2012
Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancerRafal Dziadziuszko, Murry W Wynes, Shalini Singh, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 27, 2013
Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancerNir Peled, Murry W Wynes, Norihiko Ikeda, et al.
Molecular Cancer|February 23, 2024
Small cells - big issues: biological implications and preclinical advancements in small cell lung cancerAnna Solta, Büsra Ernhofer, Kristiina Boettiger, et al.
Cancer|January 26, 2008
Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancerFred R Hirsch, Rafal Dziadziuszko, Nick Thatcher, et al.
Frontiers in Oncology|September 7, 2013
A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung CancerYuhchyau Chen, James Moon, Kishan J Pandya, et al.
Pageof 41

Showing results (161-170 of 407) with videos related to

Sort By:
Pageof 41
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2018
Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naïve LesionsKenichi Suda, Jihye Kim, Isao Murakami, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 23, 2013
Volatile fingerprints of cancer specific genetic mutationsNir Peled, Orna Barash, Ulrike Tisch, et al.
Translational Lung Cancer Research|February 4, 2020
T cell immunoglobulin and mucin-domain containing-3 in non-small cell lung cancerKeyi Jia, Yayi He, Rafal Dziadziuszko, et al.
Biomed Research International|November 10, 2017
Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell LinesKenichi Suda, Leslie Rozeboom, Koh Furugaki, et al.
Oncology Letters|June 13, 2019
Frequency and significance of epidermal growth factor receptor mutations detected by PCR methods in patients with non-small cell lung cancerEiji Nakajima, Michio Sugita, Kinya Furukawa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2012
Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancerRafal Dziadziuszko, Murry W Wynes, Shalini Singh, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 27, 2013
Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancerNir Peled, Murry W Wynes, Norihiko Ikeda, et al.
Molecular Cancer|February 23, 2024
Small cells - big issues: biological implications and preclinical advancements in small cell lung cancerAnna Solta, Büsra Ernhofer, Kristiina Boettiger, et al.
Cancer|January 26, 2008
Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancerFred R Hirsch, Rafal Dziadziuszko, Nick Thatcher, et al.
Frontiers in Oncology|September 7, 2013
A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung CancerYuhchyau Chen, James Moon, Kishan J Pandya, et al.
Pageof 41